1. Home
  2. NEO vs GRPN Comparison

NEO vs GRPN Comparison

Compare NEO & GRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • GRPN
  • Stock Information
  • Founded
  • NEO 2001
  • GRPN 2008
  • Country
  • NEO United States
  • GRPN United States
  • Employees
  • NEO N/A
  • GRPN N/A
  • Industry
  • NEO Precision Instruments
  • GRPN Advertising
  • Sector
  • NEO Health Care
  • GRPN Consumer Discretionary
  • Exchange
  • NEO Nasdaq
  • GRPN Nasdaq
  • Market Cap
  • NEO 1.2B
  • GRPN 1.2B
  • IPO Year
  • NEO 1999
  • GRPN 2011
  • Fundamental
  • Price
  • NEO $10.15
  • GRPN $17.91
  • Analyst Decision
  • NEO Buy
  • GRPN Buy
  • Analyst Count
  • NEO 10
  • GRPN 4
  • Target Price
  • NEO $12.56
  • GRPN $31.25
  • AVG Volume (30 Days)
  • NEO 4.9M
  • GRPN 1.4M
  • Earning Date
  • NEO 10-28-2025
  • GRPN 11-06-2025
  • Dividend Yield
  • NEO N/A
  • GRPN N/A
  • EPS Growth
  • NEO N/A
  • GRPN N/A
  • EPS
  • NEO N/A
  • GRPN N/A
  • Revenue
  • NEO $709,162,000.00
  • GRPN $487,747,000.00
  • Revenue This Year
  • NEO $10.74
  • GRPN $4.78
  • Revenue Next Year
  • NEO $9.85
  • GRPN $10.96
  • P/E Ratio
  • NEO N/A
  • GRPN N/A
  • Revenue Growth
  • NEO 10.10
  • GRPN N/A
  • 52 Week Low
  • NEO $4.72
  • GRPN $7.75
  • 52 Week High
  • NEO $19.12
  • GRPN $43.08
  • Technical
  • Relative Strength Index (RSI)
  • NEO 57.70
  • GRPN 39.74
  • Support Level
  • NEO $9.42
  • GRPN $18.87
  • Resistance Level
  • NEO $10.75
  • GRPN $21.58
  • Average True Range (ATR)
  • NEO 0.54
  • GRPN 1.24
  • MACD
  • NEO -0.07
  • GRPN -0.06
  • Stochastic Oscillator
  • NEO 39.68
  • GRPN 36.20

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

Share on Social Networks: